A COVID-19 Vaccine and the Role of Employers

November 18, 2020

A COVID-19 Vaccine and the Role of Employers

As COVID-19 clinical trials move closer to FDA approval, and the nation readies itself for a vaccine(s), employers are starting to think through how to best prepare operationally and support their employees from both an education and access perspective. This paper examines at a high level the science and process associated with vaccine development and approval and identifies the areas employer plan sponsors will need to contemplate as the vaccine becomes widely available. It is important to note that the data and the opinions reflected in this paper are captured in a point in time and could change rapidly based on the environment. For example, there could be some surprise vaccine entrant to the marketplace that is approved ahead of current projections, or there could be clinical trial data released next week that could change the course of vaccine development and timing.




Healthcare Library

Please be advised that any and all information, comments, analysis, and/or recommendations set forth above relative to the possible impact of COVID-19 on potential insurance coverage or other policy implications are intended solely for informational purposes and should not be relied upon as legal or medical advice. As an insurance broker, we have no authority to make coverage decisions as that ability rests solely with the issuing carrier. Therefore, all claims should be submitted to the carrier for evaluation. The positions expressed herein are opinions only and are not to be construed as any form of guarantee or warranty. Finally, given the extremely dynamic and rapidly evolving COVID-19 situation, comments above do not take into account any applicable pending or future legislation introduced with the intent to override, alter or amend current policy language.